Time-Restricted Eating Does Not Reduce Bone Density in Seven Trials: What the Research Shows

Medical disclaimer: This article summarises published research for informational purposes only. It is not medical advice and is not a substitute for guidance from a qualified health professional. Always consult your doctor before starting any fasting protocol, especially if you have an existing health condition or take medication.

Study at a Glance

What This Study Looked At

One of the most common concerns about intermittent fasting — especially among women, older adults, and anyone thinking long-term — is whether restricting eating to a daily time window could gradually weaken bones. To answer this question, a team at the University of Murcia systematically searched the published literature for all randomised controlled trials (RCTs) that had measured the effect of time-restricted eating (TRE) on bone health outcomes. The researchers screened studies from the earliest records through October 2023 and pooled the results in a formal meta-analysis. For context on how fasting affects the body overall, see What Happens to Your Body During Intermittent Fasting?.

Who Was Studied

Participant profile: Adults aged 19 to 68 years; most studies enrolled overweight or obese participants; gender breakdown varied across the 7 included trials.

How TRE worked in these studies: Participants confined all food intake to a window of typically 6–10 hours per day, fasting for the remaining 14–18 hours. No calorie targets were set in most studies — only the timing of eating was restricted. Individual studies ran between 4 and 24 weeks, with the average being 10.5 weeks.

What the Researchers Found

Bone Mineral Density (BMD)

• The difference in BMD between TRE and control groups was not statistically significant (p = 0.328). The confidence interval crossed zero, meaning there is no reliable signal of bone loss from TRE in the pooled data.
• 5 out of 7 studies reported significant weight loss in the TRE group compared to controls, confirming that participants were genuinely losing body mass.
• Despite meaningful weight loss, BMD did not decrease in TRE participants relative to controls. This is a clinically important finding: the body appears to preserve bone tissue even as fat mass drops under TRE.

Bone Turnover Markers

Bone turnover markers — including bone resorption markers (CTX, NTX) and bone formation markers (osteocalcin, P1NP) — were reported by fewer than five of the seven included studies. Because meta-analysis requires a minimum number of studies to pool results reliably, the researchers were unable to generate pooled estimates for these outcomes. Individual study findings on these markers were mixed.

What Did Not Change

• Bone mineral density remained statistically equivalent between TRE and control groups across the pooled analysis
• No significant increase in bone resorption markers was detected at the individual study level
• The preserved bone density occurred even in studies that produced significant weight loss — suggesting TRE's weight loss mechanism does not come at the cost of bone tissue

What the Researchers Concluded

The authors concluded that short- to medium-term time-restricted eating does not appear to have a detrimental effect on bone mineral density compared to unrestricted eating. They noted, however, that longer-term studies and studies specifically designed to measure bone health as a primary outcome are needed before definitive conclusions can be drawn for populations with existing bone fragility.

What This Means If You Fast

• TRE is unlikely to harm your bones in the short to medium term. Seven randomised trials found no significant BMD reduction despite meaningful weight loss. This is reassuring for people who fast regularly.
• Weight loss from other methods can reduce BMD; TRE may not carry the same risk. Caloric restriction and bariatric surgery are associated with bone loss. The TRE data, while limited, does not show the same pattern so far.
• Women post-menopause and older adults still need caution. The included studies were mostly short (average 10.5 weeks) and enrolled predominantly younger or middle-aged adults. Bone fragility accelerates after menopause. For women over 50, see Intermittent Fasting and Bone Density in Women for targeted guidance.
• Protein and resistance training remain the most important protectors of bone mass. Whether you fast or not, adequate dietary protein (25–35g per meal) and resistance exercise are the two most evidence-supported strategies for maintaining bone density. Fasting does not replace these.
• Longer studies are needed. Ten weeks is long enough to see metabolic changes but may not be long enough to detect meaningful bone changes. The absence of harm in the short term is encouraging but not a guarantee of long-term safety.
• For context on how fasting affects inflammation — a driver of bone resorption — see Does Intermittent Fasting Reduce Inflammation?.

Study Limitations

• Short study duration. The average was 10.5 weeks (range 4–24 weeks). Meaningful bone changes typically take 12–24 months to detect reliably with DEXA.
• Small sample sizes per study. With 313 participants across 7 trials, each study averaged ~45 participants. Low statistical power may have missed modest effects.
• Predominantly overweight and obese participants. Findings may not generalise to lean or osteoporotic populations at greater baseline bone risk.
• Insufficient data on bone turnover markers. Fewer than 5 studies reported these outcomes, preventing any pooled analysis of the resorption-formation dynamic.
• Mixed TRE protocols. Eating windows ranged from 6 to 10 hours across studies, limiting the ability to identify dose-response effects.
• No studies targeting bone health as the primary outcome. All included trials were primarily designed to study weight, metabolism, or cardiovascular risk — bone outcomes were secondary endpoints.
• Conflicts of interest were not reported.

Source

Fernández-Rodríguez R, Garrido-Miguel M, Bizzozero-Peroni B, Díaz-Goñi V, Rodríguez-Gutiérrez E, Guzmán-Pavón MJ, Meseguer-Henarejos AB, Torres-Costoso A. (2024). Time-Restricted Eating and Bone Health: A Systematic Review with Meta-Analysis. Nutrients, 16(6), 876. PMID: 38542787

Frequently Asked Questions

Does intermittent fasting weaken bones over time?

Based on the available evidence — seven randomised controlled trials pooled in a 2024 meta-analysis — time-restricted eating does not significantly reduce bone mineral density compared to unrestricted eating. The pooled effect was MD = −0.009 g/cm² (p = 0.328), which is not statistically meaningful. However, the studies were short (average 10.5 weeks), so the long-term picture remains unclear.

Is intermittent fasting safe for women worried about osteoporosis?

Short-term TRE appears safe for bone density based on the 2024 Nutrients meta-analysis. But women over 50 or post-menopausal women face accelerated bone loss from declining estrogen, which the included studies did not specifically address. The most protective strategies remain resistance training and adequate dietary protein — both of which work well alongside a fasting protocol.

What type of intermittent fasting was studied for bone health?

The 7 RCTs included in the meta-analysis all studied time-restricted eating (TRE), where participants confined food intake to a 6–10 hour daily window. Alternate-day fasting and 5:2 protocols were not included in this particular analysis. The results therefore apply most directly to daily TRE schedules such as 16:8 or 18:6.

Can fasting combined with resistance training protect bones?

Resistance training is one of the strongest known stimulants of bone formation. Combining resistance training with TRE is likely to preserve or improve bone density relative to TRE alone. A study by Tinsley et al. (2019) specifically on resistance-trained women found that TRE preserved lean mass — though bone density was not the primary outcome measured in that study.

Why couldn't the study pool bone turnover marker results?

Meta-analyses require a minimum number of studies (typically five or more) to generate statistically valid pooled estimates. Fewer than five of the seven included trials reported bone turnover markers (such as CTX, osteocalcin, or P1NP), so the mathematical requirements for pooling were not met. This is a gap in the current literature — future trials need to include these markers systematically.

Related Research and Articles

• Intermittent Fasting and Bone Density in Women
• Does Intermittent Fasting Destroy Muscle? Myth vs. Fact
• Intermittent Fasting and Longevity: What the Science Says
• Does Intermittent Fasting Reduce Inflammation?
• Can You Build Muscle While Intermittent Fasting?

Want the complete guide to fasting? Get Intermittent Fasting in Practice on Amazon — and claim 3 months free on our fasting app at fastinginpractice.com/redeem.